Alogliptin benzoate (Alogliptin) matières premières pharmaceutiques | Oral anti-diabetic drug

» Pharmaceutique » D'autres API » Alogliptin benzoate (Alogliptin) matières premières pharmaceutiques | Oral anti-diabetic drug

  • Caractéristiques

Buy Oral anti-diabetic drug Alogliptin benzoate (Alogliptin) matières premières pharmaceutiques (NO CAS 850649-62-6)

 

Alogliptin benzoate Quick Details

Nom du produit Alogliptin benzoate
synonymes 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate
CAS No. 850649-62-6
Formule moléculaire C18H21N5O2.C7H6O2
Poids moléculaire 461.52
Apparence poudre blanche
Boiling point 671.2°C at 760 mmHg
Essai 99%min by HPLC
Emballage 100g/bag.1Kg/bag or as demand
Application APIs

 

Alogliptin benzoate Description

Alogliptin is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class.

Alogliptin does not decrease the risk of heart attack and stroke. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of hypoglycemia, and has relatively modest glucose-lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in people whose diabetes cannot adequately be controlled with metformin alone.

formulaire ( nous reviendrons dès que possible )

prénom:
*
Email:
*
Message:

Vérification:
5 + 7 = ?

Peut-être que vous aimez aussi

  • catégories de produits

  • Messages récents

  • Partager